Financials

News Ideas Discussions Technicals Seasonals

RGT fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to ARGENT BIOPHARMA LIMITED operating, investing, and financing activities

RGT free cash flow for H2 24 is -6.88 M AUD. For 2024, RGT free cash flow was -14.8 M AUD and operating cash flow was -14.66 M AUD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: AUD

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—